Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 1
2009 1
2011 1
2013 1
2014 3
2015 4
2016 3
2017 5
2018 6
2020 2
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for M. avsar
Your search for M. Savsar retrieved no results
Treatment responses in multidrug-resistant tuberculosis in Germany.
Heyckendorf J, van Leth F, Avsar K, Glattki G, Günther G, Kalsdorf B, Müller M, Olaru ID, Rolling T, Salzer HJF, Schuhmann M, Terhalle E, Lange C. Heyckendorf J, et al. Int J Tuberc Lung Dis. 2018 Apr 1;22(4):399-406. doi: 10.5588/ijtld.17.0741. Int J Tuberc Lung Dis. 2018. PMID: 29562987
OBJECTIVE: To ascertain whether differences remain in treatment responses between patients with M/XDR-TB and those with non-M/XDR-TB. METHOD: Patients with TB were prospectively enrolled between March 2013 and March 2016 at five hospitals in Germany. ...Under optima …
OBJECTIVE: To ascertain whether differences remain in treatment responses between patients with M/XDR-TB and those with non-M/ …
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
Villar LM, Casanova B, Ouamara N, Comabella M, Jalili F, Leppert D, de Andrés C, Izquierdo G, Arroyo R, Avşar T, Lapin SV, Johnson T, Montalbán X, Fernández O, Álvarez-Lafuente R, Masterman D, García-Sánchez MI, Coret F, Siva A, Evdoshenko E, Álvarez-Cermeño JC, Bar-Or A. Villar LM, et al. Ann Neurol. 2014 Aug;76(2):231-40. doi: 10.1002/ana.24190. Epub 2014 Jul 2. Ann Neurol. 2014. PMID: 24909126
Multidrug-resistant tuberculosis in Europe, 2010-2011.
Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Pontali E, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET. Günther G, et al. Emerg Infect Dis. 2015 Mar;21(3):409-16. doi: 10.3201/eid2103.141343. Emerg Infect Dis. 2015. PMID: 25693485 Free PMC article.
We evaluated risk factors for TB and levels of second-line drug resistance in M. tuberculosis in patients in Europe with multidrug-resistant (MDR) TB. ...A total of 52.4% of MDR TB patients had never been treated for TB, which suggests primary transmission of MDR M. …
We evaluated risk factors for TB and levels of second-line drug resistance in M. tuberculosis in patients in Europe with multidrug-re …
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model.
Heyckendorf J, Marwitz S, Reimann M, Avsar K, DiNardo AR, Günther G, Hoelscher M, Ibraim E, Kalsdorf B, Kaufmann SHE, Kontsevaya I, van Leth F, Mandalakas AM, Maurer FP, Müller M, Nitschkowski D, Olaru ID, Popa C, Rachow A, Rolling T, Rybniker J, Salzer HJF, Sanchez-Carballo P, Schuhmann M, Schaub D, Spinu V, Suárez I, Terhalle E, Unnewehr M, Weiner J 3rd, Goldmann T, Lange C. Heyckendorf J, et al. Eur Respir J. 2021 Sep 2;58(3):2003492. doi: 10.1183/13993003.03492-2020. Print 2021 Sep. Eur Respir J. 2021. PMID: 33574078 Free article.
Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study.
Bothamley GH, Lange C; TBNET. Bothamley GH, et al. Respir Med. 2017 Nov;132:68-75. doi: 10.1016/j.rmed.2017.09.007. Epub 2017 Sep 23. Respir Med. 2017. PMID: 29229108 Free article.
AIM: Europe has the highest documented caseload and greatest increase in multidrug and extensively drug-resistant tuberculosis (M/XDR-TB) of all World Health Organization (WHO) regions. This survey examines how recommendations for M/XDR-TB management are being imple …
AIM: Europe has the highest documented caseload and greatest increase in multidrug and extensively drug-resistant tuberculosis (M/XDR …
Comparison of a pre-bariatric surgery very low-calorie ketogenic diet and the Mediterranean diet effects on weight loss, metabolic parameters, and liver size reduction.
Erdem NZ, Ozelgun D, Taskin HE, Avsar FM. Erdem NZ, et al. Sci Rep. 2022 Nov 30;12(1):20686. doi: 10.1038/s41598-022-24959-z. Sci Rep. 2022. PMID: 36450844 Free PMC article.

Between January 2016 and March 2017, of 45 patients enrolled, 30 completed the study (VLCKD-SDM, n = 15; MD, n = 15). Respective median BMI loss after VLCKD-SDM was 2.7 kg/m(2) versus MD 1.4 kg/m(2) (p < 0.05); median fat percentage reduction was 3.2 units versus

…
Between January 2016 and March 2017, of 45 patients enrolled, 30 completed the study (VLCKD-SDM, n = 15; MD, n = 15). Respective median BMI …
Thickness-modulated metal-to-semiconductor transformation in a transition metal dichalcogenide.
Ciarrocchi A, Avsar A, Ovchinnikov D, Kis A. Ciarrocchi A, et al. Nat Commun. 2018 Mar 2;9(1):919. doi: 10.1038/s41467-018-03436-0. Nat Commun. 2018. PMID: 29500434 Free PMC article.
Crystals with a thickness of ~13 nm show metallic behavior with a contact resistance as low as 70 omega.m. As they are thinned down to 2.5 nm and below, we observe semiconducting behavior. ...
Crystals with a thickness of ~13 nm show metallic behavior with a contact resistance as low as 70 omega.m. As they are thinned down t …
Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.
Tahan V, Avsar E, Karaca C, Uslu E, Eren F, Aydin S, Uzun H, Hamzaoglu HO, Besisik F, Kalayci C, Okten A, Tozun N. Tahan V, et al. World J Gastroenterol. 2003 Oct;9(10):2325-7. doi: 10.3748/wjg.v9.i10.2325. World J Gastroenterol. 2003. PMID: 14562402 Free PMC article.
METHODS: There were 4 groups of subjects. Group 1 consisted of 27 patients (F/M: 12/15) with NCPH due to portal and/or splenic vein thrombosis (mean age: 41+/-12 years), group 2 consisted of 14 patients (F/M: 6/8) with compensated (Child-Pugh A) cirrhosis (mean age: …
METHODS: There were 4 groups of subjects. Group 1 consisted of 27 patients (F/M: 12/15) with NCPH due to portal and/or splenic vein t …
32 results